The pathophysiology of mitochondrial disease as modeled in the mouse

Area of Science:

• Mitochondrial biology
• Genetics
• Disease mechanisms

Background:

• Mitochondrial defects are linked to numerous human and mouse clinical phenotypes due to mitochondria's role in energy, reactive oxygen species (ROS), and apoptosis.
• Mitochondrial genes are encoded by both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA).
• The causal role of mitochondrial dysfunction in common diseases, cancer, and aging remains under investigation.

Purpose of the Study:

• To demonstrate the direct cause-and-effect relationship between mitochondrial dysfunction and disease using mouse models.
• To investigate the phenotypic importance of mitochondrial defects caused by mutations in both nDNA- and mtDNA-encoded genes.
• To provide direct proof that mtDNA mutations are sufficient to cause major clinical phenotypes.

Main Methods:

• Development of mice harboring mitochondrial gene mutations (both nDNA and mtDNA).
• Introduction of specific mtDNA mutations into mouse models.
• Analysis of phenotypic consequences in mice with defined mitochondrial genetic alterations.

Main Results:

• Mutations in nDNA-encoded mitochondrial genes affecting energy metabolism, antioxidant defense, apoptosis, mitochondrial fusion, and mtDNA biogenesis have shown the importance of mitochondrial defects.
• Recent advancements allow the introduction of mtDNA mutations into mice, providing direct evidence of their sufficiency in causing clinical phenotypes.
• These mouse models are crucial for demonstrating the direct link between mitochondrial dysfunction and disease.

Conclusions:

• Mitochondrial gene mutations in mice provide definitive proof of the link between mitochondrial dysfunction and disease.
• mtDNA mutations are sufficient to generate major clinical phenotypes.
• Further research with diverse mtDNA mutations and nDNA backgrounds will clarify the role of mtDNA variation in adaptation and disease predisposition.